Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
SubB2M CA15-3
SubB2M CA125
Exo-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
29-Dec-2021
INOVIQ Appendix 4G and Corporate Governance Statement
24-Dec-2021
Chinese Patent Issued in BARD1 Patent Family for Lung Cancer
22-Dec-2021
Appendix 3Y - Change of Director's Interest Notice x 4
13-Dec-2021
Notification regarding unquoted securities - IIQ
8-Dec-2021
BARD1 Changes its Name to INOVIQ
7-Dec-2021
Cleansing Notice - Issued of Four Shares - Resolution 5 AGM
7-Dec-2021
Application for quotation of securities - BD1
2-Dec-2021
Application for quotation of securities - BD1
30-Nov-2021
Results of 2021 Annual General Meeting
29-Nov-2021
AGM Presentation
1
2
3
4
5
6
7
8
9
Next
